Form 8-K · Current report
News Corp 8-K, filed Jul 27, 2026
- Filed
- CIK
- 0001564708
- Accession no.
- 0001564708-26-000160
Summary
News Corp reported to the Australian Securities Exchange daily buy-back transactions under its 2025 Repurchase Program, which authorizes up to US$1 billion in repurchases of its Nasdaq-listed Class A and Class B common stock. Under the program, News Corp has repurchased approximately US$386,023,781 of Class A and Class B shares to date.
Key points
- News Corp reported a daily ASX buy-back notification for July 27, 2026, covering repurchases on July 24, 2026.
- News Corp bought back 70,004 securities on July 24, 2026, for US$1,870,520.88, at prices between US$26.51 and US$26.885.
- News Corp has purchased approximately US$386,023,781 worth of Class A and Class B shares under the 2025 Repurchase Program.
- The 2025 Repurchase Program authorizes up to US$1 billion in aggregate repurchases of News Corp's Nasdaq-listed Class A and Class B common stock.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 8.01Other Events
- 9.01Financial Statements and Exhibits
From the filing
Item 8.01 Other Events. As previously reported, under News Corporation's (the "Company's") stock repurchase program (the "Repurchase Program"), the Company is authorized to acquire from time to time up to $1 billion in the aggregate of the Company's outstanding shares of Class A common stock and Class B common stock. Under the rules of the Australian Securities Exchange (the "ASX"), the Company is required to provide to the ASX, on a daily basis, disclosure of transactions pursuant to the Repurchase Program, if any. The Company also discloses information concerning the Repurchase Program in the Company's quarterly and annual reports. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.